Biotech company Amgen (NASDAQ:AMGN) will be announcing earnings results this Thursday afternoon. Here’s what investors should ...

The FDA’s real-time clinical trial mechanism allows drug sponsors to transmit data immediately to the regulator through the ...

Amgen is projected to report a nearly 3% fall in its Q1 earnings on April 30, after the closing bell. The consensus EPS Estimate is $4.77, while the revenue estimate is $8.57B, tr ...

The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur, saying this could ...

A change to FDA clinical trial data review, Rocket sells its priority review voucher, and more biotech news from The Readout ...

The FDA has initiated a pilot program for real-time clinical trials, partnering with AstraZeneca and Amgen to test oncology ...

The FDA has launched two proof-of-concept studies with AstraZeneca and Amgen to test real-time safety and efficacy monitoring in oncology trials. The initiative aims to replace months-long data ...

The US Food and Drug Administration (FDA) is launching a pilot to implement real-time clinical trials (RTCT). While ...

The FDA has taken a significant step in advancing implementation of real-time clinical trials (RTCT).

The Food and Drug Administration (FDA) is set to pilot test real-time clinical trials in the hopes of expediting results and feedback, federal health officials announced on Tuesday.

The U.S. Food and Drug Administration is planning to launch a pilot program aimed at advancing real-time clinical trials ...

The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical ...